FDA panel rejects Pfizer’s COVID-19 vaccine booster in people 16 years and older
September 17, 2021 at 15:34 PM EDT
A U.S. Food and Drug Administration (FDA) advisory panel on Friday declined to endorse the Pfizer-BioNTech COVID-19 vaccine booster shot for people ages 16 years and older at least six months following the second dose.